CAS 209789-08-2

Hexanoic acid, 6,6′-oxybis[2,2-dimethyl-, calcium salt (1:1)

Description:

Hexanoic acid, 6,6′-oxybis[2,2-dimethyl-, calcium salt (1:1), identified by CAS number 209789-08-2, is a calcium salt derived from hexanoic acid, which is a medium-chain fatty acid. This compound features a unique structure that includes two 2,2-dimethyl groups and an ether linkage, contributing to its distinct properties. Typically, calcium salts of fatty acids exhibit low solubility in water but are soluble in organic solvents, making them useful in various applications, including as emulsifiers, stabilizers, and surfactants in food and cosmetic formulations. The presence of the calcium ion can enhance the stability and functionality of the compound in formulations. Additionally, the compound may exhibit antimicrobial properties, which can be beneficial in preserving products. Its safety profile generally aligns with that of other fatty acid derivatives, but specific toxicity and environmental impact assessments are essential for its use in consumer products. Overall, this compound's characteristics make it valuable in industrial and commercial applications, particularly in formulations requiring emulsification and stabilization.

Formula: C₁₆H₃₀O₅·Ca

InChI: InChI=1S/C16H30O5.Ca/c1-15(2,13(17)18)9-5-7-11-21-12-8-6-10-16(3,4)14(19)20;/h5-12H2,1-4H3,(H,17,18)(H,19,20);

InChI key: InChIKey=UVSDAPVYVXZPDP-UHFFFAOYSA-N

SMILES: C(CCCCOCCCCC(C(O)=O)(C)C)(C(O)=O)(C)C.[Ca]

Synonyms:

• Hexanoic acid, 6,6′-oxybis[2,2-dimethyl-, calcium salt (1:1)
• CI 1027
• Gemcabene calcium

Gemcabene calcium

CAS: 209789-08-2

Gemcabene calcium reduces LDL-C, cuts triglycerides, increases HDL-C, and has anti-inflammatory effects, lowering CRP.

Formula: C₁₆H₃₂CaO₅

Color and Shape: Solid

Molecular weight: 344.505

Ref: TM-T11386

Gemcabene calcium

CAS: 209789-08-2

Gemcabene calcium is a fatty acid that inhibits the formation of proteins and has been shown to be effective against atherosclerosis in animals. Gemcabene calcium also inhibits soluble guanylate cyclase and fibrinogen, which are regulatory proteins in the cell that are involved in blood clotting. The drug has been shown to have a positive effect on cardiovascular disease by reducing cholesterol levels, improving high-density lipoprotein (HDL) levels, and lowering low-density lipoprotein (LDL) levels. Gemcabene calcium analogs have been shown to be effective for treating metabolic disorders such as obesity. The drug is metabolized through hepatic cytochrome P450 enzymes, although there is no evidence of toxicity or teratogenicity from gemcabene calcium at doses up to 20 mg/kg per day.

Formula: C₁₆H₂₈CaO₅

Purity: Min. 95%

Molecular weight: 340.5 g/mol

Ref: 3D-JIA78908